SCHEMBL25579299

SCHEMBL25579299

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2N(c2ccc(-c3ccc4oc5ccccc5c4c3)cc2)c2cccc3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.36
▸ PLA2G4A P47712 4/20 0.36
▸ PLA2G10 O15496 1/20 0.35
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ MAPT P10636 4/20 0.33
▸ HPGD P15428 4/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ TSHR P16473 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ KMT2A Q03164 3/20 0.32
▸ MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25579509 0.94 CA12 (0.38) PLA2G2APLA2G4APLA2G10CA12CA1
SCHEMBL25579249 0.94 CA12 (0.38) PLA2G2APLA2G4APLA2G10CA12CA1
SCHEMBL25579292 0.94 MMP12 (0.35) PLA2G2APLA2G4APLA2G10CA12CA1
SCHEMBL25579263 0.92 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EMAPT
SCHEMBL25579357 0.92 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EMAPT
SCHEMBL25578749 0.92 KDM4E (0.34) KDM4EMAPTHPGDALDH1A1TSHR
SCHEMBL25579385 0.92 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10KDM4EMAPT
SCHEMBL25579368 0.92 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10KDM4EMAPT
SCHEMBL25577707 0.92 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10KDM4EMAPT
SCHEMBL25579329 0.91 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 PLA2G2A 2335/4885PLA2G4A 3210/4885PLA2G10 3221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback